Join us for ongoing discussions with our clinician-bloggers,
Paul Sax, MD
HIV and ID Observations
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical
Recent Posts
Long-Acting Cabotegravir-Rilpivirine for People Not Taking Oral Therapy — Time to Modify Treatment Guidelines? • September 22, 2023
HIV treatment guidelines are understandably reluctant to endorse practices that have limited data. Having served on two such panels (previously, DHHS and currently, the IAS-USA guidelines), I totally get this — you don’t want to put a stamp of approval on strategies that may ultimately do more harm than good. With the caveat that I cannot […]
2021-2022
Chief Resident Panel:
Abdullah Al‑abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Mikita Arora, MD
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Insights on Residency Training
Notes from chief residents in family and internal medicine
Recent Posts
Developing Resident Educators • August 19, 2022 • Brandon Temte, DO
We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […]
Follow us on:
Apple Podcasts
Google Podcasts
Clinical Conversations
Audio podcasts featuring the week's news,
plus your comments and pertinent interviews
Recent Posts
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 • September 2, 2022
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]
The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.The views and opinions expressed in these blogs are not necessarily those of NEJM Journal Watch or NEJM Group.
NEJM Journal Watch — Recent Infectious Diseases Articles- Missed Chances for Screening in Persons Newly Diagnosed with HIV: New York City, 2018–2022
- Arboviral Disease Surveillance in the U.S.
- Observations from ID and Beyond: Long-Acting Cabotegravir-Rilpivirine for People Not Taking Oral Therapy — Time to Change Treatment Guidelines?
- Risk for C. difficile Infection Varies Widely with Choice of Antibiotic
- Mpox in Persons with Previous Infection or Vaccination
- NEJM Journal Watch — Recent General Medicine Articles
- Do Muscle-Strengthening Activities Enhance the Mortality Benefit of Aerobic Exercise?
- Gestational Diabetes and Early Mortality
- Arboviral Disease Surveillance in the U.S.
- Observations from ID and Beyond: Long-Acting Cabotegravir-Rilpivirine for People Not Taking Oral Therapy — Time to Change Treatment Guidelines?
- Risk for C. difficile Infection Varies Widely with Choice of Antibiotic